Methicillin-resistant Staphylococcus aureus in Canada: A historical perspective and lessons learned

Canadian Journal of Microbiology

Volumn 56, Issue 2, 2010, Pages 89-120

  Cimolai, Nevio ^a,b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Infection; Infection control; Methicillin resistant; Nosocomial; Staphylococcus aureus

Indexed keywords

ESTIMATED COSTS; HISTORICAL PERSPECTIVE; INFECTION CONTROL; LESSONS LEARNED; LONG TERM CARE; MEDICAL INSTITUTIONS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH; STAPHYLOCOCCUS AUREUS; TYPING SYSTEMS; UNITED KINGDOM;

HOSPITALS; MEDICAL PROBLEMS;

MONITORING;

AMOXICILLIN; ANTIBIOTIC AGENT; CHLORHEXIDINE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; METICILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; CLONAL GROWTH; COMMUNITY STRUCTURE; DISEASE CONTROL; EPIDEMIC; EVOLUTIONARY BIOLOGY; HISTORICAL PERSPECTIVE; HOSPITAL SECTOR; INFECTIOUS DISEASE; MANAGEMENT PRACTICE; PUBLIC HEALTH;

ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM ISOLATION; BROTH DILUTION; CANADA; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMUNITY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE CONTROL; DISINFECTION; DNA SEQUENCE; EMERGENCY CARE; ENZYME SYNTHESIS; EPIDEMIC; EPIDEMIOLOGICAL DATA; EPIDERMOLYSIS BULLOSA; ERADICATION THERAPY; GENERAL HOSPITAL; GEOGRAPHIC DISTRIBUTION; GERIATRIC CARE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HOME; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NURSING HOME; ORGAN TRANSPLANTATION; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SCREENING; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; UNITED KINGDOM; UNITED STATES; UNIVERSITY HOSPITAL;

CANADA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; ENDEMIC DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFECTION CONTROL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

CANADA;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77949493597     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W09-109     Document Type: Review

References (362)

1. Adam, H., McGeer, A., and Simor, A. 2007. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can. Commun. Dis. Rep. 33(4): 45-48. PMID:17352053.
2. Adam, H., Allen, V., Borgundvaag, B., Currie, A., McGeer, A., Simor, A., et al. 2008. Risk factors for community and hospital-associated MRSA infections in patients presenting to emergency departments with staphylococcal soft tissue infections in a major Canadian city. Can. J. Infect. Dis. Med. Microbiol. 19: 109.
3. Afif, W., Huor, P., Brassard, P., and Loo, V.G. 2002. Compliance with methicillin-resistant Staphylococcus aureus precautions in a teaching hospital. Am. J. Infect. Control, 30(7): 430-433. doi:10.1067/mic.2002. 125174. PMID:12410221.
4. Al-Rawahi, G.N., Reynolds, S., Porter, S., Bowie, W.R., Kishi, L., Chong, T., et al. 2006. Characteristics of methicillin-resistant Staphylococcus aureus among patients presenting with skin and soft tissue infections to the emergency department. Can. J. Infect. Dis. Med. Microbiol. 17: 60.
5. Al-Rawahi, G.N., Schreader, A.G., Porter, S.D., Roscoe, D.L., Gustafson, R., and Bryce, E.A. 2008. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J. Clin. Microbiol. 46(2): 477-479. doi:10.1128/JCM.01596-07. PMID:18039800.
6. Allard, C., Carignan, A., Bergevin, M., Boulais, I., Tremblay, V., Robichaud, P., et al. 2008. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin. Microbiol. Infect. 14(5): 421-428. doi:10.1111/j.1469- 0691.2008.01965.x. PMID: 18325037.
7. Anderson, M.E.C., Lefebvre, S.L., and Weese, J.S. 2008. Evaluation of prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in veterinary personnel attending an international equine veterinary conference. Vet. Microbiol. 129(3-4): 410-417. doi:10.1016/j.vetmic.2007.11.031. PMID:18187274.
8. Antoniou, T., Devlin, R., Gough, K., Mulvey, M., Katz, K.C., Zehtabchi, M., et al. 2009. Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization in men who have sex with men. Int. J. STD AIDS, 20(3): 180-183. doi:10.1258/ijsa.2008.008243. PMID:19255266.
9. Association des microbiologistes infectiologues du Québec. 2003. Augmentation de la mortalité et de al morbidité dans les hôpitaux du Québec [online]. Communiqués, le juin 2003. Available from http://info.branchez-vous.com/communiques/cnw/HEA/2003/06/c97 [accessed July 2009].
10. Augustin, A., Simor, A.E., and McArthur, M. 1993. Methicillin-resistant Staphylococcus aureus in a long term care facility. Can. J. Infect. Control, 8: 69.
11. Austin, M.A., and Austin, T.W. 2001. Methicillin-resistant Staphylococcus aureus and topical decolonization: How effective is it? Can. J. Infect. Control, 16: 123-127.
12. Bannatyne, R.M., Wells, B.A., MacMillan, S.A., and Thibault, M.C. 1995. A cluster of MRSA-the little outbreak that wasn't. Infect. Control Hosp. Epidemiol. 16(7): 380. doi:10.1086/647132. PMID:7673641.
13. Barrett, F.F., McGehee, R.F., Jr., and Finland, M. 1968. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N. Engl. J. Med. 279(9): 441-448. PMID:4232865.
14. Barth, C., Thomas, E., and Manickam, K. 2002. Distribution of methicillin-resistant Staphylococcus aureus in Regina Health District - nosocomial vs. community acquired. Conjoint Mtg. Infect. Dis. 2002: P32. [Abstr.]
15. B.C. Biomedical Laboratories Ltd. 2006. Rapid changes in antibiotic susceptibilities [online]. Physicians' Newsletter IX(1): 1. Available from www.bcbio.com [accessed July 2009].
16. B.C. Biomedical Laboratories Ltd. 2008. BC Biomedical empiric therapy antibiogram 2007 [online]. Physicians' Newsletter X(1): 2. Available from www.bcbio.com [accessed July 2009].
17. Bertolin, J., Thususka, J., Harris, S., et al. 1996. Epidemiology of methicillin-resistant S. aureus at a community hospital. Conjoint Mtg. Infect. Dis. 1996: P40. [Abstr.]
18. Bigelow, N., Ng, L.K., Robson, H.G., and Dillon, J.R. 1989. Strategies for molecular characterisation of methicillin- and gentamicin-resistant Staphylococcus aureus in a Canadian nosocomial outbreak. J. Med. Microbiol. 30(1): 51-58. doi:10.1099/00222615-30-1-51. PMID:2778793.
19. Borgundvaag, B., Svoboda, T., McGeer, A., Willey, B., Rostos, A., Gnanasuntharam, P., et al. 2008. Prevalence and characterization of community acquired methicillin resistant Staphylococcus aureus colonization in high-risk individuals in Toronto, Canada. Ann. Emerg. Med. 51(4): 521-522. doi:10.1016/j.annemergmed.2008.01.136.
20. Boyd, N., and Gidwani, R. 1991. Colonization of methicillin-resistant Staphylococcus aureus in southwestern Ontario. Can. Dis. Wkly. Rep. 17(14): 72-74. PMID:2054854.
21. Bracco, D., Dubois, M.J., Bouali, R., and Eggimann, P. 2007. Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 33(5): 836-840. doi:10.1007/s00134-007-0559-5. PMID:17347828.
22. Brophy, J., Yau, Y., Cox, P., Katz, K., and Bitnun, A. 2007. A sentinel fatal pediatric case of community-associated methicillin-resistant Staphylococcus aureus in Canada. Paediatr. Child Health (Oxford), 12: 319-322.
23. Bryce, E.A., and Kerschbaumer, V. 2000. The cost of doing business - managing MRSA and VRE. Infect. Control Hosp. Epidemiol. 21: 119.
24. Bryce, E.A., Tiffin, S.M., Isaac-Renton, J.L., and Wright, C.J. 2000. Evidence of delays in transferring patients with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus to long-term-care facilities. Infect. Control Hosp. Epidemiol. 21(4): 270-271. doi:10.1086/501757. PMID:10782590.
25. Buchanan-Chell, M., and Taylor, G. 1993. Stable six-year trends in community-based source of methicillin-resistant Staphylococcus aureus. Can. J. Infect. Control, 8: 67.
26. Buchanan-Chell, M., Chui, L., Tyrrell, G., and Taylor, G. 2004. Evolution of a methicillin resistant Staphylococcus aureus outbreak following introduction of a Japanese strain. Can. J. Infect. Control, 19: 17.
27. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control. 1986. Canadian nosocomial infection surveillance program. Can. Dis. Wkly. Rep. 12(Suppl.).
28. Bureaux of Infection Control and Epidemiology 1984. Methicillin-resistant Staphylococcus aureus - Canada. Can. Dis. Wkly. Rep. 10: 26-28.
29. Burt, J., Garcia, M., Kennedy, C., et al. 1998. The epidemiology of methicillin-resistant Staphylococcus aureus Ontario epidemic strain over 3 years at The Toronto Hospital. Conjoint Mtg. Infect. Dis.1998: P15. [Abstr.]
30. Burton, J., and Varga, S. 1982. Methicillin-resistant Staphylococcus aureus - Ontario. Can. Dis. Wkly. Rep. 8: 161-163.
31. Callery, S., Vearncombe, M., and Simor, A. 2009. Universal screening for methicillin resistant Staphylococcus aureus: Have we missed the target? Can. J. Infect. Control, 24: 43.
32. Campbell, J.L., Spreitzer, J.D., Mulvey, M.R., and Ng, L.K. 2004. Pulsed-field gel electrophoresis typing of methicillin-resistant Staphylococcus aureus in Canada: an exercise in the standardization of methods and nomenclature. Conjoint Mtg. Infect. Dis. 2004: B3. [Abstr.]
33. Carrier, M., Marchand, R., Auger, P., Hébert, Y., Pellerin, M., Perrault, L.P., et al. 2002. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J. Thorac. Cardiovasc. Surg. 123(1): 40-44. doi:10.1067/mtc.2002.118505. PMID: 11782754.
34. Chagla, Z., Salvadori, M., Hussain, Z., Chagla, Y., and John, M. 2008. Community acquired methicillin resistant Staphylococcus aureus in London, Ontario: a 30 month retrospective study. Can. J. Infect. Dis. Med. Microbiol. 19: 106-107.
35. Chambers, C., Roth, V.R., Ouellet, C., Bruce, N., Shymanski, J., and Suh, K.N. 2008. The effect of inadequate facilities on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus rates in vascular surgery patients. Can. J. Infect. Control, 23: 45.
36. Charlebois, M., Lau, W., Louie, M., Conly, J., Gregson, M.D., Louie, T., et al. 2007a. Enhanced population-based surveillance for CMRSA10 (USA300) in a large Canadian health region. Can. J. Infect. Dis. Med. Microbiol. 18: 47.
37. Charlebois, M., Lau, W., MacDonald, J., Conly, J., Gregson, D., HopeK., et al. 2007b. Enhanced population-based surveillance for CMRSA-10 (USA300) in a large Canadian population. Can. J. Infect. Control, 22: 53.
38. Charlong, M.E. 1984. Methicillin-resistant Staphylococcus aureus - Ontario. Can. Dis. Wkly. Rep. 10: 25-26.
39. Christensen, L.B., Snelling, C.F.T., Boyle, J.C., et al. 1992. Management of an epidemic - methicillin resistant Staphylococcus aureus. Clin. Invest. Med. 15(Suppl.): A77.
40. Christianson, S., Golding, G.R., Campbell, J., and Mulvey, M.R.; Canadian Nosocomial Infection Surveillance Program. 2007. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45(6): 1904-1911. doi:10.1128/JCM.02500- 06. PMID:17428941.
41. Chui, L., Chang, N., Bethune, R., et al. 1997. Transmission of methicillin-resistant S. aureus from donor to recipients by organ transplantation. Conjoint Mtg. Infect. Dis. 1997: Ps31. [Abstr.]
42. Chui, L., Lovgren, M., Heinrichs, B., Keays, G., Simmonds, K., and Louie, M. 2007. Province-wide laboratory surveillance for methicillin-resistant Staphylococcus aureus in Alberta. Can. J. Infect. Dis. Med. Microbiol. 18: 42.
43. Cimolai, N. 2002. Are all MRSA made equal? Can. J. Microbiol. 48(6): 560-566. doi:10.1139/w02-045. PMID:12166684.
44. Cimolai, N. 2003. Staphylococcus aureus outbreaks among newborns: new frontiers in an old dilemma. Am. J. Perinatol. 20(3): 125-136. doi:10.1055/s-2003-40010. PMID:12802712.
45. Cimolai, N. 2006a. Community-acquired MRSA infection: an emerging trend. B. C. Med. J. 48(3): 116-120.
46. Cimolai, N. 2006b. Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort. Am. J. Ophthalmol. 142(1): 183-184. doi:10.1016/j.ajo.2006.02.019. PMID:16815280.
47. Cimolai, N. 2007a. MRSA control and the counter-culture. J. Hosp. Infect. 66(2): 189-190. doi:10.1016/j.jhin.2007.03.022. PMID: 17512632.
48. Cimolai, N. 2007b. Methicillin-resistant Staphylococcus aureus public concern, and legislative mandates. Infect. Control Hosp. Epidemiol. 28(7): 896. doi:10.1086/519913. PMID:17674465.
49. Cimolai, N. 2008a. MRSA and the environment: implications for comprehensive control measures. Eur. J. Clin. Microbiol. Infect. Dis. 27(7): 481-493. doi:10.1007/s10096-008-0471-0. PMID: 18273652.
50. Cimolai, N. 2008b. The role of healthcare personnel in the maintenance and spread of methicillin-resistant Staphylococcus aureus. J. Infect. Public Health, 1(2): 78-100. doi:10.1016/j.jiph.2008.10.001.
51. Cimolai, N. 2009. The anatomy of an outbreak: lessons learned from an outbreak of methicillin-resistant Staphylococcus aureus among newborns and a review of the literature. In Methicillin-resistant Staphylococcus aureus (MRSA): etiology, at-risk populations and treatment. Edited by C.L. Kolendi. Nova Science Publishers, Inc. Hauppauge, N.Y. In press.
52. Cimolai, T., and Cimolai, F. 2009. On the genesis of MRSA in Canada [online]. CMAJ eLetters. Available from http://www.cmaj.ca/cgi/eletters/180/4/ 408#85469 [accessed July 2009].
53. Cimolai, N., and Espersen, F. 2001. Staphylococcal infections. In Laboratory diagnosis of bacterial infections. Edited by N. Cimolai. Marcel Dekker Inc. New York, N.Y. pp. 229-255.
54. Clarke, A.M., and Zemcov, S.J.V. 1984. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other β-lactams. J. Antimicrob. Chemother. 13(2): 121-128. doi:10.1093/jac/13.2.121. PMID:6323375.
55. Clarke, A.M., and Zemcov, S.J.V. 1989. Comparative in vitro activity of lomefloxacin, a new difluoroquinolone. Eur. J. Clin. Microbiol. Infect. Dis. 8(2): 164-168. doi:10.1007/BF01963905. PMID:2498101.
56. Clarke, A.M., and Zemcov, S.J.V. 1991. In vitro activity of the novel cephalosporin GR69153. Eur. J. Clin. Microbiol. Infect. Dis. 10(8): 683-687. doi:10.1007/BF01975826. PMID:1748126.
57. Clarke, A.M., Zemcov, S.J.V., and Campbell, M.E. 1985. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new b-lactams. J. Antimicrob. Chemother. 15(1): 39-44. doi:10.1093/jac/15.1.39. PMID:3156112.
58. Clarke, A.M., Zemcov, S.J.V., and Hubinette, M.M. 1994. Comparative in vitro activity of FK-037, a new cephalosporin antibiotic. Diagn. Microbiol. Infect. Dis. 20(1): 27-32. doi:10.1016/0732-8893(94)90015-9. PMID:7867295.
59. Clinical Microbiology Proficiency Testing Program. 2001. M013-2 Boil (nursing home patient): methicillin-resistant Staphylococcus aureus [online]. November 2001. Available from http://www.cmpt.ca/critiques-00-2002/ m013-2nov-01.pdf [accessed July 2009].
60. Clinical Microbiology Proficiency Testing Program. 2002. M022-3 Leg wound: methicillin-resistant Staphylococcus aureus [online]. August 2001. Avai lable from http://www.cmpt.ca/critiques-00-2002/m022-3aug-02.pdf [accessed July 2009].
61. Clinical Microbiology Proficiency Testing Program. 2004. M043-2. Wound (impetigo): Group A streptococcus and methicillin-resistant Staphylococcus aureus [online]. November 2004. Available from ht tp://www.cmpt.ca/cri t iques-2004/m043-2-wnd-nov-04.pdf [accessed July 2009].
62. Clinical Microbiology Proficiency Testing Program. 2006. M061-2. Nares: MRSA - methicillin-resistant Staphylococcus aureus [online]. November 2004. Available from http://www.cmpt.ca/critiques-2006/m061-2-nose-mrsa-may-06. pdf [accessed July 2009].
63. Collet, J.C., Koch, L., Anderson, B., Dekleer, R., and Gagan, V. 2008. Methicillin-resistant Staphylococcus aureus admission screening at BC Children's Hospital. Can. J. Infect. Control, 23: 56.
64. Comité sur les infections nosocomiales du Québec. 2006. Mesures de prévention et de contrôle des infections à Staphylococcus aureus résistant a la méthicilline au Québec. Institut national de santé publique du Québec, Québec, QC.
65. Conly, J., Embil, J., Nicolle, L., Alfa, M., Taylor, G., Louie, T., et al. 1993. Methicillin-resistant Staphylococcus aureus: the Canadian prairie experience 1990-1992. Clin. Invest. Med. Abstr. 16(Suppl.): B79.
66. Conly, J.M., Stiver, H.G., Weiss, K.A., Becker, D.L., Rosner, A.J., and Miller, E. 2003. A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres. Can. J. Infect. Dis. 14(6): 315-321. PMID:18159474.
67. Conly, J., Gilbert, M., Zhang, K., Gregson, D., Elsayed, S., Mulvey, M., et al. 2005. Rapidly progressive fatal necrotizing pneumonitis to Panton-Valentine+, SCCmec type IVa community-acquired methicillin-resistant S. aureus - a harbinger of the future? Conjoint Mtg. Infect. Dis. 2005: G5. [Abstr.]
68. Conly, J., Mah, M., Holton, D., Elsayed, S., Gregson, D., Zhang, K., et al. 2007. Hospital transmission of community associated methicillin-resistant Staphylococcus aureus in the Calgary Health Region. Can. J. Med. Microbiol. Infect. Dis. 18: 40-41.
69. Conterno, L.O., Shymanski, J., Ramotar, K., Toye, B., van Walraven, C., Coyle, D., and Roth, V.R. 2007. Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus: impact on nosocomial transmission and costs. Infect. Control Hosp. Epidemiol. 28(10): 1134-1141. doi:10.1086/520099. PMID:17828689.
70. Cook, P., McGhie, K., Goertz, N., John, M., and Card, M.L. 2008. Hand hygiene compliance in non-acute care settings. Can. J. Infect. Control, 23: 59.
71. Cooper, K.L., Dyck, B., Nicoll, D., Olekson, K., McLeod, J., Nicolle, L., et al. 1999. Bed utilization for the inpatient care of patients infected or colonized with methicillin-resistant Staphylococcus aureus in a Canadian tertiary care centre. Can. J. Infect. Control, 14: 2.
72. Cooper, C.L., Dyck, B., Ormiston, D., Olekson, K., McLeod, J., Nicolle, L.E., and Embil, J.M. 2002. Bed utilization of patients with methicillin-resistant Staphylococcus aureus in a Canadian tertiary-care center. Infect. Control Hosp. Epidemiol. 23(9): 483-484. doi:10.1086/503472. PMID:12269441.
73. Dalloo, A., Sobol, I., Palacios, C., Mulvey, M., Gravel, D., and Panaro, L. 2008. Investigation of community-associated methicillin-resistant Staphylococcus aureus in a remote northern community, Nunavut, Canada. Can. Commun. Dis. Rep. 34(5): 1-7. PMID:18802983.
74. Daly, P.C., Bryce, E.A., Buxton, J.A., and Weatherill, S. 2001. Prevalence of methicillin-resistant Staphylococcus aureus among injection drug users in an inner city. Conjoint Mtg. Infect. Dis. 2001: A1. [Abstr.]
75. Daly, P., Bryce, E.A., and Buxton, J. 2002. Reply to Dr. Charlebois et al. (Clin. Infect. Dis. 34: 425-433). Clin. Infect. Dis. 35(9): 1135. doi:10.1086/342325. PMID:12384849.
76. Dammann, T.A., Wiens, R.M., and Taylor, G.D. 1988. Methicillin resistant Staphylococcus aureus: identification of a community outbreak by monitoring of hospital isolates. Can. J. Public Health, 79(5): 312-314. PMID:3179904.
77. Davis, L., White, D., Alexander, D., Drews, S.J., Pikula, Z., and Katz, K.C. 2005. MRSA in long term care and its impact on acute care. Can. J. Infect. Control, 20: 44.
78. de Lencastre, H., Sá Figueiredo, A.M., Urban, C., Rahal, J., and Tomasz, A. 1991. Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 35(4): 632-639. PMID:2069369.
79. Defalco, K., MacFarlane, S., Ouellet, C., et al. 2008. The effectiveness of MRSA admission screening in a rehabilitation centre. Can. J. Infect. Control, 23: 62.
80. Desmarais, N., and Perpête, C. 2002. Dépistage des bactéries résistantes. Pourquoi? [online]. Available from http://www.chu-sainte-justine.org/documents/Pro/Depistage-bacteries.pdf. [Accessed July 2009.]
81. Devlin, H.R., McKernan, P., Urbach, D., Arthurs, K., and Tennant W. 1989. Two distinct epidemics of methicillin resistant Staphylococcus aureus occurring simultaneously in one institution. Conjoint Mtg. Infect. Dis. 1989: C3. [Abstr.]
82. Dhaliwal, J., and Moore, C. 2006. Factors associated with MRSA acquisition in contacts of MRSA colonized/infected patients in an acute care hospital. Can. J. Infect. Control, 21: 23.
83. Diekema, D.J., Pfaller, M.A., Turnidge, J., Verhoef, J., Bell, J., Fluit, A.C., et al.; Sentry Participants Group. 2000. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb. Drug Resist. 6(3): 213-221. doi:10.1089/mdr.2000.6.213. PMID:11144421.
84. Diekema, D.J., Pfaller, M.A., Schmitz, F.J., Smayevsky, J., Bell, J., Jones, R.N., and Beach, M.; SENTRY Partcipants Group. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2): S114-S132. doi:10.1086/320184. PMID:11320452.
85. Dow, C.M. 1982. Methicillin-resistant Staphylococcus aureus - Ontario. Can. Dis. Wkly. Rep. 8: 39.
86. Doyle, T., Taylor, M., Bruce, N., Suh, K.N., and Roth, V. 2007. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in your hospital: not if, but when? Can. J. Infect. Control, 22: 53.
87. Drisdelle, G.M., Haldane, D.J.M., and Forward, K.R. 1998. Evaluation of four media for the recovery of methicillin-resistant Staphylococcus aureus from surveillance cultures. Conjoint Mtg. Infect. Dis. 1998: P19. [Abstr.]
88. Dubois, J., and Fontaine, V. 1988. In-vitro activity of fleroxacin against urinary tract and genital tract pathogens. J. Antimicrob. Chemother. 22(Suppl. D): 31-34. PMID:3144546.
89. Dubois, J., Martel, A., and Saad, W.P. 1986. In vitro activities of enoxacin and CI-934 against urinary tract and gastrointestinal tract pathogens. Curr. Ther. Res. 40: 1084-1089.
90. Duff, Z., Ouellet, C., and Roth, V. 2004. Can the environment play a supporting role in an intransigent outbreak of methicillin resistant Staphylococcus aureus? Can. J. Infect. Control, 19: 19.
91. Duhaime, C. 1997. Controlling MRSA. Can. J. Infect. Control, 12: 38.
92. Dyck, B., and Nicolle, L. 1993. An outbreak of methicillin-resistant Staphylococcus aureus on an acute medical ward. Can. J. Infect. Control, 8: 69.
93. Elder, R., Richardson, H., Stoot, D., and Wood, D.E. 1986. Difficulties in detecting methicillin resistance in Staphylococcus aureus in a laboratory proficiency testing program. Conjoint Mtg. Infect. Dis. 1986: C11. [Abstr.]
94. Ellison, J., Laupland, K., Tilley, P., et al. 2006. The epidemiology of methicillin-resistant Staphylococcus aureus in Southern Alberta. Can. J. Infect. Control, 21: 30.
95. Elsayed, S., Zhang, K., McClure, J., Gregson, D., Louie, T., and Conly, J. 2006. Molecular and phenotypic analysis of community-acquired methicillin-resistant Staphylococcus aureus strains in a large Canadian urban healthcare region. Can. J. Infect. Dis. Med. Microbiol. 17: 44.
96. Elsayed, S., Zhang, K., Gregson, D., Louie, T., and Conly, J. 2007. Fusidic acid susceptibility of methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus in a regional healthcare system. Can. J. Infect. Dis. Med. Microbiol. 18: 67.
97. Embil, J., Ramotar, K., Romance, L., Alfa, M., Conly, J., Cronk, S., et al. 1994. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect. Control Hosp. Epidemiol. 15(10): 646-651. doi:10.1086/646827. PMID:7844335.
98. Embil, J., Almuneef, M., Nicoll, D., Makki, S., Cunningham, G., Wylie, J., et al. 2001a. Methicillin-resistant Staphylococcus aureus: profiles oceans apart-Canadian and Saudi Arabian experiences. J. Chemother. 13(Suppl. 1): 28-33. PMID:11434526.
99. Embil, J.M., McLeod, J.A., Al-Barrak, A.M., Thompson, G.M., Aoki, F.Y., Witwicki, E.J., et al. 2001b. An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns, 27(7): 681-688. doi:10.1016/S0305-4179(01) 00045-6. PMID:11600247.
100. Faires, M.C., Gard, S., Aucoin, D., and Weese, J.S. 2009. Inducible clindamycin-resistance in methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius isolates from dogs and cats. Vet. Microbiol. 139(3-4): 419-420. doi:10.1016/j.vetmic.2009. 06.016. PMID:19592178.
101. Farkas-Himsley, H., Soeprihatin, S.D., and Goldner, M. 1964a. Detection of unusual penicillin-resistant clinical staphylococci. Can. J. Public Health, 55: 38.
102. Farkas-Himsley, H., Soeprihatin, S.D., and Goldner, M. 1964b. A rapid procedure for screening unusual penicillin-resistant clinical strains of staphylococci. Nature, 202(4931): 514-515. doi:10.1038/202514a0. PMID:14167852.
103. Fedorko, J., and Katz, S. 1960. Laboratory comparison of a new synthetic penicillin, dimethoxyphenyl penicillin, with a-phenoxyethyl penicillin and penicillin G. In: A symposium on the new dimethoxyphenyl penicillin: early laboratory and clinical experiences with particular reference to resistant staphylococcal disease. Edited by Bunn, P.A. Upstate Medical Centre, Syracuse, NY. pp.201-205.
104. Fleming, P.C. 1974. Antibiotic chemotherapy in infections: problem of multiple resistance. Hosp. Top. 52(9): 18, 20.
105. Fleming, P.C., Goldner, M., and Glass, D.G. 1963. Observations on the nature, distribution, and significance of cephalosporinase. Lancet, 1(7296): 1399-1401. doi:10.1016/S0140-6736(63) 92051-8. PMID:13945492.
106. Fluet, K., and McKenzie, M. 1999. MRSA cases in the Capital Health Region more than doubles in 1998. Can. J. Infect. Control, 14: 21.
107. Forward, K.R., and Arbique, J.C. 1996. A study of the yield from surveillance cultures for methicillin resistant S. aureus during a hospital outbreak. Conjoint Mtg. Infect. Dis. 1996: I2. [Abstr.]
108. Forward, K.R., and Arbique, J.C. 1997. Cumulative yield from patient surveillance cultures for methicillin-resistant Staphylococcus aureus during a hospital outbreak. Infect. Control Hosp. Epidemiol. 18(11): 776-778. doi:10.1086/647537. PMID:9397376.
109. Forward, K.R., Franks, P.A., Low, D.E., Rennie, R., and Simor, A.E. 1998. Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics. Can. J. Infect. Dis. 9: 33-44.
110. Fung, S.K., Dedier, H., Izatt, S., et al. 1998. Lack of colonization by methicillin-resistant Staphylococcus aureus, mupirocin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in a chronic ambulatory peritoneal dialysis population. Conjoint Mtg. Infect. Dis. 1998: P8. [Abstr.]
111. Galarneau, L.A., Gourdeau, M., and Jetté, L. 1999. Progression alarmante des SARM au Québec. AMMIQale, 7: 46-47.
112. Galarneau, L.A. et al. 2004. 29e congrès d'Association des microbiologistes infectiologues du Québec, Juin 2004.
113. Galarneau, L.A., Jetté, L., Frenette, C., et al. 2007. Surveillance des bactériémes à Staphylococcus aureus: rapport 2006. Institut national de santé publique du Québec, Québec, Québec.
114. Gamage, B., Varia, M., Litt, M., Pugh, S., and Bryce, E.; PICNet Needs Assessment Working Group. 2008. Finding the gaps: an assessment of infection control surveillance needs in British Columbia acute care facilities. Am. J. Infect. Control, 36(10): 706-710. doi:10.1016/j.ajic.2008.06.004. PMID:18945521.
115. Garceau, R. 2008. SARM, ERV, BSLE: acquisition, précautions et conduite par le médecin de premiere ligne. Association des médecins de langue française du Canada, 2008.
116. Gardam, M.A., Campbell, I., Dedier, H., Weinwurm, D., and Conly, J. 1998. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis. Conjoint Mtg. Infect. Dis. 1998: P14. [Abstr.]
117. Gardam, M., Brunton, J., Willey, B., McGeer, A., Low, D., and Conly, J. 2001. A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 22(3): 152-156. doi:10.1086/501882. PMID:11310693.
118. Gauthier, J., McDonald, S., Zoutman, D., and Siebel, J. 2004. Time interval from exposure to detection of MRSA: culturing once is not enough. Can. J. Infect. Control, 19: 18.
119. Gauthier, J., Campbell, D., Zoutman, D., and Lloyd, L. 2005. Outbreak of MRSA detected through occupational health. Can. J. Infect. Control, 20: 40.
120. Gilbert, M, Gregson D, Gillespie J, et al. 2005a. Clinical features of community-acquired methicillin-resistant S. aureus skin and soft tissue infections in an outbreak in persons with histories of drug use, homelessness or incarceration. Conjoint Mtg. Infect. Dis. 2005: G6. [Abstr.]
121. Gilbert, M, Siushansian J, MacDonald J, et al. 2005b. An outbreak of the USA300 strain of community-acquired methicillin-resistant Staphylococcus aureus infections in individuals with histories of drug use, homelessness or incarceration. Conjoint Mtg. Infect. Dis. 2005: G2. [Abstr.]
122. Gilbert, M., Conly, J., MacDonald, J., et al. 2006a. Possible role of sexual activity in propagation of an outbreak of CMRSA-10 community-acquired methicillin-resistant Staphylococcus aureus in a marginalized urban population. Can. J. Infect. Dis. Med. Microbiol. 17: 31.
123. Gilbert, M., MacDonald, J., Gregson, D., Siushansian, J., Zhang, K., Elsayed, S., et al. 2006b. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ, 175(2): 149-154. PMID:16804118.
124. Gin, A.S., Saunders, D.G., Hoban, D., Kabani, A., Karlowsky, J., and Nicolle, L. 1995. Increasing antibiotic resistance against enterococcal species and staphylococcal species in a tertiary care medical centre, 1984-1994. Conjoint Mtg. Infect. Dis. 1995: Ps1. [Abstr.]
125. Goetghebeur, M., Landry, P.A., Han, D., and Vicente, C. 2007. Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences. Can. J. Infect. Dis. Med. Microbiol. 18(1): 27-34. PMID:18923684.
126. Goh, S.-H., Byrne, S.K., Zhang, J.L., and Chow, A.W. 1992. Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J. Clin. Microbiol. 30(7): 1642-1645. PMID:1352784.
127. Gold, W.L., Ng, J., Goldman, C., et al. 1994. The epidemiology of methicillin-resistant Staphylococcus aureus in acute care facilities: it may not be too late. Clin. Invest. Med. 17: B73.
128. Golding, G.R., Campbell, J.L., Spreitzer, D.J., Veyhl, J., Surynicz, K., Simor, A., and Mulvey, M.R.; Canadian Nosocomial Infection Surveillance Program. 2008a. A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Can. J. Infect. Dis. Med. Microbiol. 19(4): 273-281. PMID:19436507.
129. Golding, G.R., Mulvey, M.R., Levett, P.N., McDonald, R.R., and Irvine, J. 2008b. Characterization of community-associated methicillin-resistant and -sensitive Staphylococcus aureus infections in three northern Saskatchewan communities. Can. J. Infect. Dis. Med. Microbiol. 19: 127.
130. Government of Prince Edward Island. 2008a. Queen Elizabeth Hospital provides update on VRE and MRSA. [online]. Available from http://www.gov.pe.ca/news/getrelease.php3?number=5753 [accessed July 2009].
131. Government of Prince Edward Island. 2008b. Queen Elizabeth Hospital taking extra precautions [online].Available from http://www.gov.pe.ca/ news/getrelease.php3?number=6017 [accessed July 2009].
132. Gravenkemper, C.F., Brodie, J.L., and Kirby, W.M.M. 1965. Resistance of coagulase-positive staphylococci to methicillin and oxacillin. J. Bacteriol. 89: 1005-1010. PMID:14276086.
133. Green, K., Fleming, C.A., McGeer, A., Low, D.E., and Richardson, H. 1996. Methicillin-resistant Staphylococcus aureus in Ontario. Conjoint Mtg. Infect. Dis. 1996: I1. [Abstr.]
134. Green, K., Fleming, C.A., McGeer, A., Richardson, H., and Low, D.E. 1997. Dramatic emergence of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Conjoint Mtg. Infect. Dis. 1997: H3. [Abstr.]
135. Green, K., Saginur, M., Fleming, C.A., Low, D.E., and McGeer, A. 2000. MRSA in Ontario - can transmission be controlled? Can. J. Infect. Control, 15: 16.
136. Guerrero, J., O'Grady, S., Takata-Schewchuk, J., and Gardam, M. 2006. Usefulness of post-antibiotic treatment screening for methicillin resistant Staphylococcus aureus in a complex continuing care facility. Can. J. Infect. Control, 21: 31.
137. Haase, D., Urias, B., Harding, G., and Ronald, A. 1983. Comparative in vitro activity of norfloxacin against urinary tract pathogens. Eur. J. Clin. Microbiol. 2(3): 235-241. doi:10.1007/BF02029524. PMID:6224679.
138. Hammerberg, O., Bialkowska-Hobrzanska, H., Gregson, D., McGhie, K., and Behme, R. 1995. Diversity of methicillin-resistant Staphylococcus aureus isolated in a Canadian hospital. Eur. J. Clin. Microbiol. Infect. Dis. 14(3): 199-205. doi:10.1007/BF02310356. PMID:7614960.
139. Hanselman, B.A., Kruth, S.A., Rousseau, J., and Weese, J.S. 2008. Methicillin-resistant Staphylococcus aureus colonization in schoolteachers in Ontario. Can. J. Infect. Dis. Med. Microbiol. 19(6): 405-408. PMID:19436569.
140. Harnett, N., Brown, S., and Krishnan, C. 1990. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario. Conjoint Mtg. Infect. Dis. 1990: H11. [Abstr.]
141. Harnett, N., Brown, S., and Krishnan, C. 1991. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob. Agents Chemother. 35(9): 1911-1913. PMID:1952866.
142. Heinrichs, B., Honish, A., Keays, G., Simmonds, K., and Hare, L. 2006. Development of a community acquired methicillin resistant Staphylococcus aureus provincial outbreak investigation protocol. Can. J. Infect. Control, 21: 23.
143. Heinrichs, B., Keays, G., Hansen, B., and Hare, L. 2007. Development of provincial methicillin resistant Staphylococcus aureus infection prevention and control guidelines. Can. J. Infect. Control, 22: 38.
144. Henry, D., Kunzer, L., Ngui-Yen, J., and Smith, J. 1986. Comparative
145. Hoban, D.J. 1989. In-vitro activity of a new penem FCE 22101. J. Antimicrob. Chemother. 23(Suppl C): 53-57. PMID:2786518.
146. Hoban, D., Waites, K., and Felmingham, D. 2003. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagn. Microbiol. Infect. Dis. 45(4): 251-259. doi:10.1016/S0732-8893(02)00522- 9. PMID:12729995.
147. Huletsky, A., Lebel, P., Picard, F.J., Bernier, M., Gagnon, M., Boucher, N., and Bergeron, M.G. 2005. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin. Infect. Dis. 40(7): 976-981. doi:10.1086/428579. PMID:15824989.
148. Hull, M.W., Champagne, S., Goh, S.H., McNabb, A., and Romney, M.G. 2006. Characterization of community-associated methicillin-resistant Staphylococcus aureus (MRSA) among clinical isolates at Providence Health Care, Vancouver, British Columbia. Can. J. Infect. Dis. Med. Microbiol. 17: 31.
149. Hull, M., Champagne, S., Goh, S.H., and Romney, M. 2007. High prevalence of PVL-positive community associated MRSA isolates from clinical isolates at Providence Health Care, Vancouver, BC. Can. J. Infect. Dis. Med. Microbiol. 18: 48.
150. Hull, M., Lloyd-Smith, E., Champagne, S., et al. 2008. High prevalence and persistence of methicillin-resistant Staphylococcus aureus in a downtown Vancouver community. Can. J. Infect. Dis. Med. Microbiol. 19: 90.
151. Irvine, J., Quinn, B., Stockdale, D., et al. 2008. Dissemination of community-associated methicillin-resistant Staphylococcus aureus in northern Saskatchewan. Can. J. Infect. Dis. Med. Microbiol. 19: 86.
152. Janvier, J., Elsayed, S., Gregson, D., et al. 2006. Necrotizing pneumonia secondary to community-acquired methicillin-resistant S. aureus USA300 strain without evidence of antecedent viral respiratory tract infection. Can. J. Infect. Dis. Med. Microbiol. 17: 30.
153. Janz, L., Wang, L., Born, J., et al. 2006. A genotyping study of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates from British Columbia. Can. J. Infect. Dis. Med. Microbiol. 17: 49.
154. Jeans, E.R., Jayaratne, P., Luchsinger, I.S., and Hendry, A.T. 1994. DNA typing methods are more effective than phage-typing in investigation of an outbreak of methicillin-resistant Staphylococcus aureus. Conjoint Mtg. Infect. Dis. 1994: PS11. [Abstr.]
155. Jessamine, P., Ramotar, K., Desjardins, M., Roth, V., and Toye, B. 2007. Clinical and epidemiologic features of patients with CMRSA-7 or CMRSA-10 at a tertiary care hospital. Can. J. Infect. Dis. Med. Microbiol. 18: 47.
156. Jetté, L., and Frenette, C. 2004. Surveillance des infections envahissantees à S. aureus, rapport 2004. Institut National de Santé Publique du Québec. Québec, Québec.
157. Jetté, L., and Ismaïl, J. 2001. Programme de surveillance passive de Staphylococcus aureus résistant à la méthicilline. Laboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec. Rapport annuel, 2001.
158. Johnston, L., Chui, L., Chang, N., Macdonald, S., McKenzie, M., Kennedy, W., et al. 1999. Cross-Canada spread of methicillin-resistant Staphylococcus aureus via transplant organs. Clin. Infect. Dis. 29(4): 819-823. doi:10.1086/520442. PMID:10589896.
159. Jones, R.N., Kohno, S., Ono, Y., Ross, J.E., and Yanagihara, K. 2009. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn. Microbiol. Infect. Dis. 64(2): 191-201. doi:10.1016/j.diagmicrobio.2009. 03.001. PMID: 19500528.
160. Kennedy, C., Weinwurm, D., Rappoccio, M., et al. 1999. Reduction of nosocomial methicillin-resistant Staphylococcus aureus occurrences at the Toronto Hospital: effects of intervention or natural history? Can. J. Infect. Control, 14: 3.
161. Khan, A., Lampitoc, M., Salaripour, M., McKernan, P., Devlin, R., and Muller, M. 2008. Rapid control of MRSA outbreak in a medical surgical intensive care unit. Can. J. Infect. Control, 23: 56-57.
162. Khan, A., Lampitoc, M., Salaripour, M., McKernan, P., Devlin, R., and Muller, M.P. 2009. Rapid control of a methicillin resistant Staphylococcus aureus (MRSA) outbreak in a medical surgical intensive care unit (ICU). Can. J. Infect. Control, 24(1): 12-16. PMID:19517879.
163. Khanna, T., Friendship, R., Dewey, C., and Weese, J.S. 2008. Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet. Microbiol. 128(3-4): 298-303. doi:10.1016/j.vetmic.2007.10.006. PMID:18023542.
164. Kim, T., Oh, P.I., and Simor, A.E. 2001. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect. Control Hosp. Epidemiol. 22(2): 99-104. doi:10.1086/501871. PMID:11232886.
165. Kreiswirth, B., Kornblum, J., Eisner, W., Scriver, S.R., Low, D.E., and Simor, A.E. 1991. Retrospective analysis of the emergence of ciprofloxacin resistant methicillin-resistant Staphylococcus aureus. Conjoint Mtg. Infect. Dis. 1991: G5. [Abstr.]
166. Kurbis, C.A., and Wylie, J.L. 2001. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can. J. Infect. Dis. 12(3): 149-152. PMID:18159332.
167. Kureishi, A., Lam-Li, D., O'Neil, L., Sissons, K., and Gibb, A.P. 1997. Results of screening for methicillin resistant Staphylococcus aureus carriage in health care workers. Can. J. Infect. Control, 12: 37.
168. Lagacé-Wiens, P.R.S., Alfa, M.J., Manickam, K., and Harding, G.K.M. 2008. Reductions in workload and reporting time by use of methicillin-resistant Staphylococcus aureus screening with MRSASelect medium compared to mannitol-salt medium supplemented with oxacillin. J. Clin. Microbiol. 46(4): 1174-1177. doi:10.1128/JCM.01253- 07. PMID:18234863.
169. Laing, F., Henwick, S, and Ramotar, K. 2001. Outbreak of mupirocin-resistant MRSA in a community hospital. Conjoint Mtg. Infect. Dis. 2001: R4. [Abstr.]
170. Laing, F., McWhinney, K., Ramotar, K., et al. 2004. The epidemiology of methicillin-resistant Staphylococcus aureus in the Fraser Health Authority. Can. J. Infect. Control, 19: 20.
171. Larcombe, L., Waruk, J., Schellenberg, J., and Ormond, M. 2007. Rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) among children and adolescents in northern Manitoba, 2003-2006. Can. Commun. Dis. Rep. 33(2): 9-14. PMID: 17233122.
172. Laupland, K.B., Church, D.L., Mucenski, M., Sutherland, L.R., and Davies, H.D. 2003. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J. Infect. Dis. 187(9): 1452-1459. doi:10.1086/374621. PMID:12717627.
173. Laupland, K., Ross, T., and Gregson, D. 2008a. Epidemiology of Staphylococcus aureus bloodstream infections in a large Canadian health region, 2000-2006. Can. J. Infect. Dis. Med. Microbiol. 19: 93.
174. Laupland, K.B., Ross, T., and Gregson, D.B. 2008b. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J. Infect. Dis. 198(3): 336-343. doi:10.1086/589717. PMID:18522502.
175. Laverdière, M., Weiss, K., Rivest, R., and Delorme, J. 1998. Trends in antibiotic resistance of staphylococci over an eightyear period: differences in the emergence of resistance between coagulase positive and coagulase-negative staphylococci. Microb. Drug Resist. 4(2): 119-122. doi:10.1089/mdr.1998.4.119. PMID:9650998.
176. LeBlanc, L., Pépin, J., Toulouse, K., Ouellette, M.F., Coulombe, M.A., Corriveau, M.P., and Alary, M.E. 2006. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg. Infect. Dis. 12(9): 1398-1405. PMID:17073089.
177. Ledgerwood, D., Hope, K., Hume, K., Henderson, E., Ramotar, K., and Louie, T. 1993. One hospital's experience with methicillin-resistant Staphylococcus aureus. Can. J. Infect. Control, 8: 64.
178. Lee, C., Griffith-Turner, M., Korver, J., and Smaill, F. 2002. Reduction in rate of nosocomial MRSA with the implementation of screening high-risk patients on admission program. Conjoint Mtg. Infect. Dis. 2002: D3. [Abstr.]
179. Lefebvre, S.L., Reid-Smith, R., Boerlin, P., and Weese, J.S. 2008. Evaluation of the risks of shedding Salmonellae and other potential pathogens by therapy dogs fed raw diets in Ontario and Alberta. Zoonoses Public Health, 55(8-10): 470-480. PMID: 18811908.
180. Lefebvre, S.L., Reid-Smith, R.J., Waltner-Toews, D., and Weese, J.S. 2009. Incidence of acquisition of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and other health-careassociated pathogens by dogs that participate in animal-assisted interventions. J. Am. Vet. Med. Assoc. 234(11): 1404-1417. doi:10.2460/javma.234.11.1404. PMID:19480620.
181. Legeard, D., Callery, S., Dunfield, L., et al. 1996. Epidemiological profile of MRSA in a tertiary care hospital. Conjoint Mtg. Infect. Dis. 1996: P39. [Abstr.]
182. Lesyk, D. 2007. Implementation of a MRSA-reduction protocol lowers the rate of MRSA colonization in residents in a longterm care facility. Can. J. Infect. Control, 22: 52.
183. Leung, T., Lakhani, A., Cheng, L., Arikan, Y., Purych, D., and Grunfeld, A. 2008. Evaluation of outpatient treatment of CAMRSA in skin and soft tissue infections in a large health authority. Can. J. Infect. Dis. Med. Microbiol. 19: 86.
184. Lobbedez, T., Gardam, M., Dedier, H., Burdzy, D., Chu, M., Izatt, S., et al. 2004. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol. Dial. Transplant. 19(12): 3140-3143. doi:10.1093/ndt/gfh494. PMID:15466881.
185. Loeb, M.B., Craven, S., McGeer, A.J., Simor, A.E., Bradley, S.F., Low, D.E., et al. 2003. Risk factors for resistance to antimicrobial agents among nursing home residents. Am. J. Epidemiol. 157(1): 40-47. doi:10.1093/aje/kwf173. PMID:12505889.
186. Louie, M., Chui, L., Elsayed, S., and Mulvey, M. 2006. Community acquired methicillin resistant Staphylococcus aureus in Alberta. Public Health Division, Alberta Health and Wellness, Edmonton, Alberta.
187. Low, D.E., Garcia, M., Callery, S., et al. 1981. Methicillin-resistant Staphylococcus aureus - Ontario. Can. Dis. Wkly. Rep. 7: 249-250.
188. Low, D.E., Kreiswirth, B.N., Weiss, K., and Willey, B.M. 2002. Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus. Int. J. Antimicrob. Agents, 20(3): 220-222. doi:10.1016/S0924-8579(02)00132-2. PMID:12385702.
189. MacCannell, D., Krulicki, W., Ramotar, K., Ward, L., Vansteelandt, A., and Louie, T.J. 2004. Molecular analysis of historical methicillin-resistant Staphylococcus aureus isolates from Southern Alberta. Can. J. Infect. Control, 19: 9-10.
190. MacKenzie, A.M.R., Wood, D.E., Missett, P., and Richardson, H. 1991. Sensitivity of detection of methicillin resistant Staphylococcus aureus by laboratories in Ontario. Conjoint Mtg. Infect. Dis. 1991: D14. [Abstr.]
191. Mackenzie, A.M.R., Richardson, H., Missett, P., Wood, D.E., and Groves, D.J. 1993. Accuracy of reporting of methicillin-resistant Staphylococcus aureus in a provincial quality control program: a 9-year study. J. Clin. Microbiol. 31(5): 1275-1279. PMID: 8501229.
192. Mackenzie, A.M., Richardson, H., Lannigan, R., and Wood, D. 1995. Evidence that the National Committee for Clinical Laboratory Standards disk test is less sensitive than the screen plate for detection of low-expression-class methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 33(7): 1909-1911. PMID:7665669.
193. Maclean Smith, I., and Counts, G.W. 1960. Laboratory and clinical studies of dimethoxyphenyl penicillin. In A symposium on the new dimethoxyphenyl penicillin: early laboratory and clinical experiences with particular reference to resistant staphylococcal disease. Edited by P.A. Bunn. Upstate Medical Centre, Syracuse, N.Y. pp. 83-92.
194. Main, C.L., Jayaratne, P., Haley, A., Rutherford, C., Smaill, F., and Fisman, D.N. 2005. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can. J. Infect. Dis. Med. Microbiol. 16(6): 343-348. PMID:18159517.
195. Martel, C., Ramotar, K., Ouellet, C., Jessamine, P., Toye, B., and Roth, V. 2001 Mannitol-negative methicillin-resistant Staphylococcus aureus (mn-MRSA): are you missing them? Conjoint Mtg. Infect. Dis. 2001: J3. [Abstr.]
196. McArthur, M., O'Quinn, K., Jaeger, R., Low, D.E., Simor, A.E., and McGeer, A. 1993. Prevalence of methicillin-resistant Staphylococcus aureus in Ontario in long term care facilities. Can. J. Infect. Control, 8: 79.
197. McArthur, M., McGeer, A., Watt, C., et al. 2006. Where did this MRSA come from? Can. J. Infect. Control, 21: 23.
198. McConnell, J.M., Dick, P., Gregg, E., and Gardam, M. 2009. An outbreak of CA-MRSA 10 involving newborns and parents associated with a colonized healthcare worker. Can. J. Infect. Control, 24: 41.
199. McGeer, A., Low, D.E., Conly, J., Campbell, I., Willey, B., and Simor, A. 1996. The rapid emergence of a new strain of MRSA in Ontario: laboratory and infection control implications. Laboratory Proficiency Testing Program Newsletter, 190: 1-4.
200. McGeer, A., Low, D., Conly, J., Campbell, I., Devlin, R., Simor, A., and Gregson, D. 1997. Methicillin-resistant Staphylococcus aureus in Ontario. Can. Commun. Dis. Rep. 23(6): 45-46. PMID:9094793.
201. McGeer, A., Fleming, C.A., Green, K., and Low, D.E. 2001. Antimicrobial resistance in Ontario: are we making progress? Laboratory Proficiency Testing Program Newsletter, 293: 1-4.
202. McGeer, A., Fleming, C.A., Willey, B.M., Green, K.A., and Low, D.E. 2008. Antimicrobial resistance in common hospital pathogens in Ontario. Quality Management Program Laboratory Services News, 131: 4-14.
203. McGuire, M., Barry, C., Vearncombe, M., Simor, A., Fish, J., and Nyog Inn, N. 2005. A methicillin resistant Staphylococcus aureus outbreak in a regional burn unit: lessons learned. Can. J. Infect. Control, 20: 38.
204. McGuire, M., Vearncombe, M., Gomez, M., Fish, J., and Callery, S. 2006. Comparing outcomes of methicillin resistant Staphylococcus aureus positive and negative acute burn patients: infection control does make a difference. Can. J. Infect. Control, 21: 23.
205. MDS Metro Laboratory Services. 2005a. Burnaby reference laboratory overview [online.] Available from http://www.lifelabs.com/files/BC/healthcare/ Micro-stats-for-2005-BRL.pdf [accessed July 2009].
206. MDS Metro Laboratory Services. 2005b. Victoria reference laboratory overview [online]. Available from http://www.lifelabs.com/files/BC/ healthcare/Micro-stats-for-2005-VRL.pdf [accessed July 2009].
207. Miller, M.A., Orenstein, P., and Amihod, B. 1995. Attitudes and beliefs of Canadian infection control decision-makers towards 'borderline' methicillin-resistant Staphylococcus aureus. Can. J. Infect. Control, 10(4): 114-116. PMID:8547683.
208. Miller, M.A., Dascal, A., Portnoy, J., and Mendelson, J. 1996. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect. Control Hosp. Epidemiol. 17(12): 811-813. doi:10.1086/647242. PMID:8985769.
209. Minion, J., Saxinger, L., Chui, L., Fuller, J., and Taylor, G.D. 2008. MRSA bloodstream infection: epidemiologic and clinical characteristics in one institution over a seven year period. Can. J. Infect. Dis. Med. Microbiol. 19: 109.
210. Moore, C., Dhaliwal, J., Tong, A., Eden, S., Wigston, C., Willey, B., and McGeer, A. 2008. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acutecare hospital. Infect. Control Hosp. Epidemiol. 29(7): 600-606. doi:10.1086/588567. PMID:18624667.
211. Motlagh, B., Rutherford, C., Bialachowski, A., and Main, C.L. 2005. Second outbreak of MRSA infection in a correction facility in southern Ontario. Conjoint Mtg. Infect. Dis. 2005: P1.30. [Abstr.]
212. Mufti, A.H., Desjardins, M., Ramotar, K., Guibord, C., and Toye, B. 2005. Mupirocin resistance in methicillin-resistant Staphylococcus aureus at a tertiary care hospital (1997-2003). Conjoint Mtg. Infect. Dis. 2005: P1.07. [Abstr.]
213. Mulvey, M.R., Chui, L., Ismail, J., Louie, L., Murphy, C., Chang, N., and Alfa, M.; Canadian Committee for the Standardization of Molecular Methods. 2001. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 39(10): 3481-3485. doi:10.1128/JCM.39.10.3481-3485.2001. PMID:11574559.
214. Mulvey, M.R., Campbell, J.L., Watt, C., et al. 2004. Emergence of three new epidemic strains of MRSA in Canada. Conjoint Mtg. Infect. Dis. 2004: B4. [Abstr.]
215. Mulvey, M.R., MacDougall, L., Cholin, B., Horsman, G., Fidyk, M., and Woods, S.; Saskatchewan CA-MRSA Study Group. 2005. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg. Infect. Dis. 11(6): 844-850. PMID:15963278.
216. Mulvey, M., Ofner, M., Campbell, J., et al. 2008. Methicillin-resistant Staphylococcus aureus identified in hospitalized patients with no risk factors for healthcare-associated transmission. Can. J. Infect. Dis. Med. Microbiol. 19: 83.
217. Nadarajah, J., Lee, M.J.S., Louie, L., Jacob, L., Simor, A.E., Louie, M., and McGavin, M.J. 2006. Identification of different clonal complexes and diverse amino acid substitutions in penicillin-binding protein 2 (PBP2) associated with borderline oxacillin resistance in Canadian Staphylococcus aureus isolates. J. Med. Microbiol. 55(Pt 12): 1675-1683. doi:10.1099/jmm.0.46700-0. PMID:17108271.
218. Nankoosingh, V., Dedier, H., Manning-Atwell, K., Kenny, S., Nielsen, P., Iverson, K., et al. 2006. Methicillin resistant Staphylococcus aureus outbreak in a chiropody clinic. Can. J. Infect. Control, 21: 37.
219. Nankoosingh, V., Dedier, H., Manning-Atwell, T., Kenny, S., Nielsen, P., Stockton, M., et al. 2007. Methicillin resistant Staphylococcus aureus outbreak in a chiropody clinic. Can. J. Infect. Control, 22: 48.
220. Nath, S.K., Shea, B., Jackson, S., and Rotstein, C. 1995. Ribotyping of nosocomial methicillin-resistant Staphylococcus aureus isolates from a Canadian hospital. Infect. Control Hosp. Epidemiol. 16(12): 717-724. doi:10.1086/647046. PMID:8683090.
221. CBC News. 2008a. Superbug becoming a major problem in North, health officials warn [online]. Available from http://www.cbc.ca/canada/north/ story/2008/08/01/north-mrsa.html [accessed July 2009].
222. CBC News. 2008b. MRSA outbreak delays surgeries at Charlottetown hospital [online]. Available from http://www.cbc.ca/canada/prince-edward-island/ story/2008/12/18/pe-mrsa-surgery.html [accessed July 2009].
223. Nichol, K.A., Decorby, M.R., Lagacé-Wiens, P.R.S., McCracken, M., Mulvey, M.R., Hoban, D.J., et al. 2008. Comparison of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and hospital-acquired MRSA (HA-MRSA) in Canada: results from CANWARD 2007. Can. J. Infect. Dis. Med. Microbiol. 19: 127.
224. Nichol, K.A., McCracken, M., DeCorby, M.R., Thompson, K.R., Mulvey, M.R., Karlowsky, J.A., et al. 2009. Comparison of community-associated and health-care associated methicillin-resistant Staphylococcus aureus in Canada: results from CANWARD 2007. Can. J. Infect. Dis. Med. Microbiol. 20(Suppl. A): 31A-36A.
225. Nicolle, L.E., Bialkowska-Hobrzanska, H., Romance, L., Harry, V.S., and Parker, S. 1992. Clonal diversity of methicillin-resistant Staphylococcus aureus in an acute-care institution. Infect. Control Hosp. Epidemiol. 13(1): 33-37. doi:10.1086/646420. PMID:1545110.
226. Nicolle, L.E., Dyck, B., Thompson, G., Roman, S., Kabani, A., Plourde, P., et al.; Manitoba Chapter of CHICA-Canada. 1999. Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 20(3): 202-205. doi:10.1086/501613. PMID:10100549.
227. Noel, G.E., Jette, L.P., Cournoyer, R., Ducic, S., and Morisset, R. 1989. Profile of an outbreak of methicillin-resistant Staphylococcus aureus in a burn unit. Conjoint Mtg. Infect. Dis. 1989: C4. [Abstr.]
228. Northwest Territories Department of Health and Social Services. 2007. Superbugs a growing concern [online]. Available from http://www.exec.gov.nt.ca/ currentnews/prDetails.asp?varPR-ID=1104 [accessed July 2009].
229. O'Grady, S.E., and Conly, J.M. 1998. Screening patients for methicillin-resistant Staphylococcus aureus on admission to a chronic care and rehabilitation hospital. Conjoint Mtg. Infect. Dis. 1998: P20. [Abstr.]
230. O'Neill, C., Vanzuilen, L., Dunnett, S., Wiley, B., Sarabia, A., and Yamamura, D. 2002. Mupirocin resistance in methicillin resistant Staphylococcus aureus in the Niagara region, Ontario. Conjoint Mtg. Infect. Dis. 2002: D2. [Abstr.]
231. O'Quinn, K., McArthur, M., Scriver, S.R., Jaeger, R., Low, D., and McGeer, A. 1992. Screening for methicillin resistant Staphylococcus aureus in Ontario long term care facilities. Conjoint Mtg. Infect. Dis. 1992: B6. [Abstr.]
232. O'Shea, T.M.,Main, C., and Rutherford, C. 2006. Community-acquired methicillin-resistant Staphylococcus aureus: the epidemiology of an emerging pathogen. Can. J. Infect. Dis. Med. Microbiol. 17: 59-60.
233. Ofner-Agostini, M., Simor, A.E., Mulvey, M., Bryce, E., Loeb, M., McGeer, A., et al.; Canadian Nosocomial Infection Surveillance Program, Health Canada. 2006. Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infect. Control Hosp. Epidemiol. 27(2): 204-207. doi:10.1086/500628. PMID:16465642.
234. Ofner-Agostini, M., Varia, M., Johnston, L., Green, K., Simor, A., Amihod, B., et al.; Canadian Nosocomial Infection Surveillance Program. 2007. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am. J. Infect. Control, 35(9): 563-568. doi:10.1016/j.ajic.2006.12.003. PMID:17980232.
235. Olde, J., Knight, S., Robinson, K., Harrison, B., and Loeb, M. 1999. Effectiveness of the Ontario Nursing Home Association guidelines for the management of MRSA in long term care facilities in preventing the transmission of MRSA in a long term care setting. Can. J. Infect. Control, 14: 8.
236. Orvidas, M.C., Gittens Webber, C., Ramage, L., Smaill, F., and Loeb, M. 2007. Outbreak of community associated methicillin resistant Staphylococcus aureus in a level III neonatal intensive care unit. Can. J. Infect. Control, 22: 52-53.
237. Ossip, M., Burt, J., and Conly, J. 1998a. A retrospective analysis of the eradication of the carrier state for methicillin resistant Staphylococcus aureus in transplant patients. Clin. Invest. Med. Suppl. S60: 268. [Abstr.]
238. Ossip, M., Burt, J., and Conly, J. 1998b. Analysis of the eradication of the carrier state for methicillin-resistant Staphylococcus aureus in solid organ transplant patients. Conjoint Mtg. Infect. Dis. 1998: F5. [Abstr.]
239. Ouellet, V.R., Bailey, C.D., Shymanski, J., Taylor, M., Jessamine, P.G., and Roth, V.R. 2001. Designing an outbreak of methicillin resistant Staphylococcus aureus. Conjoint Mtg. Infect. Dis. 2001: P68. [Abstr.]
240. Oughton, M.T., Dick, H.L.N., Willey, B.M., et al. 2001. Methicillin-resistant Staphylococcus aureus as a cause of infections in domestic animals: evidence for a new humanotic disease? Conjoint Mtg. Infect. Dis. 2001: R2. [Abstr.]
241. Page, B., Jones, C., Stevens, D., and Groves, D. 1991. Problems with the detection of methicillin resistant Staphylococcus aureus (MRSA) in the clinical laboratory. Conjoint Mtg. Infect. Dis. 1991: G3. [Abstr.]
242. Papadopoulos, C., McGeein, R., Glasgow, K., and McGeer, A. 1997. Identification and eradication of methicillin resistant Staphylococcus aureus in Brant County. Can. J. Infect. Control, 12: 37.
243. Papakyriacou, H., Vaz, D., Simor, A., Louie, M., and McGavin, M.J. 2000. Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 181(3): 990-1000. doi:10.1086/315342. PMID:10720522.
244. Papia, G., Louie, M., Tralla, A., Johnson, C., Collins, V., and Simor, A.E. 1999. Screening high-risk patients for methicillinresistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect. Control Hosp. Epidemiol. 20(7): 473-477. doi:10.1086/501655. PMID:10432159.
245. Paradis, R., Delage, G., Dion, R., et al. 1998. Infections en émergence au Québec: état de la situation et perspectives. Ministère de la santé et des Services sociaux , Québec, Que. Publ. No. 97-210-10F.
246. Perna, S., Beaudry, C., Zakaratos, J., and Loo, V. 2001. Effectiveness of universal screening program versus targeted screening for the early detection of community-acquired MRSA. Conjoint Mtg. Infect. Dis. 2001: R1. [Abstr.]
247. Peskun, C. 2007. Interdisciplinary collaboration in the management of staff during a methicillin resistant Staphylococcus aureus outbreak at a paediatric hospital. Can. J. Infect. Control, 22: 39.
248. Phillips, D., and Witherspoon, D. 1998. Invasion of the superbugs: a retrospective analysis of an outbreak of MRSA in a long term care facility in Edmonton. Can. J. Infect. Control, 13: 12.
249. Picard, F.J., Jetté, L.P., Rochefort, J., and Brazeau, M. 1987. Staphylococcus aureus strains associated with food poisoning in Quebec. Can. J. Public Health, 78(1): 21-24. PMID:3828934.
250. Pike, J.H., and McLean, D. 2002. Ethical concerns in isolating patients with methicillin-resistant Staphylococcus aureus on the rehabilitation ward: a case report. Arch. Phys. Med. Rehabil. 83(7): 1028-1030. doi:10.1053/apmr.2002.33108. PMID: 12098167.
251. Poutanen, S.M., Vearncombe, M., McGeer, A.J., Gardam, M., Large, G., and Simor, A.E. 2005. Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome. Infect. Control Hosp. Epidemiol. 26(2): 134-137. doi:10.1086/502516. PMID:15756882.
252. Poutanen, S.M., Green, K., Willey, B., et al. 2006. The introduction of SCCmec Type IV Panton-Valentine leukocidin-positive MRSA in Canada. 46th Ann. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 2006. Abstr.
253. Preston, M., Borczyk, A., and Jamieson, F. 1998a. Epidemic methicillin-resistant Staphylococcus aureus strain - Ontario. Can. Commun. Dis. Wkly. 24-06.
254. Preston, M.A., Borczyk, A.A., and Jamieson, F. 1998b. Isolation of methicillin-susceptible Staphylococcus aureus strain homologous to the Ontario epidemic MRSA strain. Conjoint Mtg. Infect. Dis. 1998: L2. [Abstr.]
255. Purych, D., and Taylor, G. 1998. Methicillin resistant Staphylococcus aureus in a Canadian tertiary care institution - a ten year experience. Can. J. Infect. Control, 13: 4.
256. Quach, C., Frenette, C., Gilca, R., Rocher, I., and Moore, D. 2007. Surveillance provinciale des bactériémies nosocomiales sur cathéters centraux aux soins intensifs: Avril 2006 - Mars 2007. Laboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec.
257. Ramotar, K., Desjardins, M., Roth, V., and Toye, B. 2007. Trends in the molecular epidemiology of methicillin resistant Staphylococcus aureus in eastern Ontario. Can. J. Infect. Dis. Med. Microbiol. 18: 80-81.
258. Ravaoarinoro, M., and Therrien, C. 1996. Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci. Int. J. Antimicrob. Agents, 7(3): 167-170. doi:10.1016/S0924- 8579(96)00317-2. PMID:18611752.
259. Rennie, R.P. 2006. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data. J. Cutan. Med. Surg. 10(6): 277-280. PMID:17241597.
260. Rennie, R., Brosnikoff, C., Shokoples, S., Turnbull, L., and Kidson, P. 2006. Seven-year surveillance of Staphylococcus aureus susceptibility to fusidic acid in a Canadian hospital. Can. J. Infect. Dis. Med. Microbiol. 17: 40-41.
261. Rennie, R., Brosnikoff, C., Shokoples, S., et al. 2007. Surveillance of the susceptibility of Staphylococcus aureus to fusidic acid isolated in four Canadian laboratories. Can. J. Infect. Dis. Med. Microbiol. 18: 37-38.
262. Rennie, R., Brosnikoff, C., Harris, M., et al. 2008. Bi-annual surveillance of Staphylococcus aureus susceptibility to fusidic acid in five Canadian laboratories. Can. J. Infect. Dis. Med. Microbiol. 19: 93.
263. Rhodenizer-Rose, S., Watson, E., and Nestel, M. 2007. MRSA task force: a frontline approach to decreasing hospital-acquired MRSA transmission. Can. J. Infect. Control, 22: 44.
264. Ritchie, P., Mah, M., Gregson, D., and Alfieri, N. 2008. Does MRSA screening have an effect on nosocomial transmission? Results from an admission screening protocol initiated after detection of an MRSA cluster in an ICU. Can. J. Infect. Control, 23: 61.
265. Roberts, F.J. 1980. A review of positive blood cultures: identification and source of microorganisms and patterns of sensitivity to antibiotics. Rev. Infect. Dis. 2(3): 329-339. PMID:6774401.
266. Rockwell, F., Goh, S.H., Al-Rawahi, G., et al. 2005. A report on the emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in British Columbia, 23 November 2005 [online]. Available from http://www.llbc.leg.bc.ca/public/PubDocs/bcdocs/403687/CAMRSA.pdf [accessed July 2009].
267. Roman, R.S., Smith, J., Walker, M., Byrne, S., Ramotar, K., Dyck, B., et al. 1997. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin. Infect. Dis. 25(3): 698-705. doi:10.1086/513758. PMID:9314464.
268. Romance, L., Nicolle, L., Ross, J., and Law, B. 1991. An outbreak of methicillin-resistant Staphylococcus aureus in a pediatric hospital - how it got away and how we caught it. Can. J. Infect. Control, 6(1): 11-13. PMID:1824273.
269. Ross, C., Louie, T., Alfieri, N., et al. 2004. Incidence of MRSA colonization among healthcare workers and physicians in a cardiovascular surgical program. Can. J. Infect. Control, 19: 15.
270. Rostas, A., Willey, B.M., Cudek, E., Moussa, M., and Low, D.E. 2008. Molecular epidemiology and antibiotic susceptibilities of methicillin-resistant Staphylococcus aureus in emergency room patients over 6 years. Can. J. Infect. Dis. Med. Microbiol. 19: 108.
271. Roth, V., Ramotar, K., Jessamine, P., Oxley, C., Devries, B., Garber, G., et al. 1998a. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Ottawa-Carleton. Conjoint Mtg. Infect. Dis. 1998: L1. [Abstr.]
272. Roth, V., Toye, B., Oxley, C., Sample, M.L., Suh, K., Bruneau, M.A., et al. 1998b. Epidemiology of methicillin-resistant Staphylococcus aureus at an Ottawa tertiary care hospital. Can. J. Infect. Control, 13: 13.
273. Ruzo, G., Willey, B.M., Famiglietti, A., Vay, C., McGeer, A., and Low, D.E. 1998. Molecular comparison between methicillin-resistant Staphylococcus aureus isolated in Buenos Aires, Argentina and Ontario, Canada. Conjoint Mtg. Infect. Dis. 1998: L6. [Abstr.]
274. Sabath, L.D., Barrett, F.F., Wilcox, C., Gerstein, D.A., and Finland, M. 1969. Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 8: 302-306.
275. Salaripour, M., McKernan, P., and Devlin, R.; Infection Prevention and Control Team. 2006. A multidisciplinary approach to reducing outbreaks and nosocomial MRSA in a university-affiliated hospital. Healthc. Q. 9(Spec No): 54-60. PMID:17087169.
276. Saunders, A., Panaro, L., McGeer, A., Rosenthal, A., White, D., Willey, B.M., et al. 2007. A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can. J. Infect. Dis. Med. Microbiol. 18(2): 128-132. PMID:18923766.
277. Saxinger, L., Pisani, C., Fuller, J., and Chandran, U. 2008. The meteoric rise of MRSA as a proportion of Staphylococcus isolates from skin and soft tissue infections in two outpatient IV clinics, Edmonton, Canada. Can. J. Infect. Dis. Med. Microbiol. 19: 92.
278. Scriver, S.R., Willey, B.M., Low, D.E., and Simor, A.E. 1992. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 11(7): 646-652. doi:10.1007/BF01961677. PMID:1396778.
279. Semret, M., and Miller, M.A. 2001. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect. Control Hosp. Epidemiol. 22(9): 578-580. doi:10.1086/501956. PMID:11732789.
280. Shahin, R., Johnson, I.L., Jamieson, F., McGeer, A., Tolkin, J., and Ford-Jones, E.L.; Toronto Child Care Center Study Group. 1999. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch. Pediatr. Adolesc. Med. 153(8): 864-868. PMID:10437762.
281. Shea, B., Thornley, J., Jayarantne, P., and Nath, S. 1993. Spread of methicillin-resistant Staphylococcus aureus in a general hospital: characterization of strains by ribotyping. Conjoint Mtg. Infect Dis. 1993: P10. [Abstr.]
282. Shik, J., Burr, J., Campbell, I., Kennedy, C., McNeely, D., and Conly, J. 1998. Methicillin-resistant Staphylcoccus aureus (MRSA) pseudobacteremia with the Ontario epidemic strain. Conjoint Mtg. Infect. Dis. 1998: P17. [Abstr.]
283. Silverman, A., and Gardam, M. 2008. Universal MRSA admission screening for psychiatry inpatients in a large urban teaching hospital. Can. J. Infect. Control, 23: 48.
284. Simmonds, K., Dover, D., and Sanderson, M. 2008. Community acquired MRSA and socioeconomic status. Can. J. Infect. Control, 23: 48.
285. Simor, A.E., Augustin, A., Ng, J., Tsimidis, K., and McArthur, M. 1992. Investigation of a cluster of methicillin-resistant Staphylococcus aureus infections in a long-term care facility. Conjoint Mtg. Infect. Dis. 1992: B1. [Abstr.]
286. Simor, A.E., Augustin, A., Ng, J., Betschel, S., and McArthur, M. 1994. Control of MRSA in a long-term care facility. Infect. Control Hosp. Epidemiol. 15(2): 69-70. doi:10.1086/646861. PMID:8201234.
287. Simor, A., Ofner-Agostini, M., and Paton, S. 1997. The Canadian Nosocomial Infection Surveillance Program: results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can. Commun. Dis. Rep. 23(6): 41-45. PMID:9094792.
288. Simor, A.E., Ofner-Agostini, M., Paton, S., Johnson, W., Mulvey, M.R., and Lee, M. 1998. Methicillin-resistant Staphylococcus aureus in Canadian hospitals: the first two years of national surveillance. Can. J. Infect. Control, 13: 13.
289. Simor, A.E., Boyd, D., Louie, L., McGeer, A., Mulvey, M., and Willey, B.M. 1999a. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can. J. Infect. Dis. 10: 333-336.
290. Simor, A., Boyd, D., Louie, L., McGeer, A., Mulvey, M., and Willey, B. 1999b. Characterization and proposed nomenclature of epidemic strains of methicillin-resistant Staphylococcus aureus in Canada. Can. Commun. Dis. Rep. 25(12): 105-108. PMID:10390904.
291. Simor, A.E., Boyd, D., Louie, L., McGeer, A., Mulvey, M., and Willey, B.M. 1999c. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Can. J. Infect. Control, 14: 97-100.
292. Simor, A., Ofner-Agostini, M., Onno, S., et al. 1999d. The evolution of methicillin resistant Staphylococcus aureus in Canadian hospitals: four years of national surveillance. Can. J. Infect. Control, 14: 6-7.
293. Simor, A.E., Kim, T., and Oh, P. 2000a. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can. J. Infect. Control 15: 2-3.
294. Simor, A.E., Ofner-Agostini, M., Bryce, E., Green, K., McGeer, A., Mulvey, M., and Paton, S. 2000b. Methicillin-resistant Staphylococcus aureus in Canada: five years of national surveillance. Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 40: 70.
295. Simor, A.E., Kim, T., and Oh, P. 2001a. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect. Control Hosp. Epidemiol. 22(2): 99-104.
296. Simor, A.E., Ofner-Agostini, M., Bryce, E., McGeer, A., Paton, S., McIver, M.R., et al. 2001b. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: the results of five years of national surveillance 1995-1999. Conjoint Mtg. Infect. Dis. 2001: A2. [Abstr.]
297. Simor, A.E., Ofner-Agostini, M., Bryce, E., Green, K., McGeer, A., Mulvey, M., and Paton, S.; Canadian Nosocomial Infection Surveillance Program, Health Canada. 2001c. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ, 165(1): 21-26. PMID:11468949.
298. Simor, A.E., Ofner-Agostini, M., Bryce, E., McGeer, A., Paton, S., and Mulvey, M.R.; Canadian Hospital Epidemiology Committee and Canadian Nosocomial Infection Surveillance Program, Health Canada. 2002a. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. J. Infect. Dis. 186(5): 652-660. doi:10.1086/342292. PMID:12195352.
299. Simor, A.E., Ofner-Agostini, M., Mulvey, M., McGeer, A., Bryce, E., Loeb, M., et al. 2002b. Methicillin-resistant Staphylococcus aureus surveillance in Canada, 1995-2001. Conjoint Mtg. Infect. Dis. 2002: D1. [Abstr.]
300. Simor, A.E., McGeer, A., Bryce, E., Loeb, M., Mulvey, M., Gravel, D., et al. 2005a. Nine years of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Conjoint Mtg. Infect. Dis. 2005: G1. [Abstr.]
301. Simor, A.E., Ofner-Agostini, M., Gravel, D., Varia, M., Paton, S., McGeer, A. et al. 2005b. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals - a report update from the Canadian Nosocomial Infection Surveillance Program. Can. Commun. Dis. Rep. 31. Available from http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/ dr3103a-eng.php?option=print [accessed July 2009].
302. Simor, A.E., Ofner-Agostini, M., Paton, S., McGeer, A., Loeb, M., Bryce, E., and Mulvey, M.; Canadian Nosocomial Infection Surveillance Program. 2005c. Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients. Infect. Control Hosp. Epidemiol. 26(10): 838-841. doi:10.1086/502503. PMID:16276960.
303. Simor, A.E., Stuart, T.L., Louie, L., Watt, C., Ofner-Agostini, M., Gravel, D., et al.; Canadian Nosocomial Infection Surveillance Program. 2007a. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51(11): 3880-3886. doi:10.1128/AAC.00846-07. PMID:17724154.
304. Simor, A.E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H.R., and Kiss, A. 2007b. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin. Infect. Dis. 44(2): 178-185. doi:10.1086/510392. PMID:17173213.
305. Simor, A.E., Stuart, T.L., Louie, L., Watt, C., Ofner-Agostini, M., Gravel, D., et al.; Canadian Nosocomial Infection Surveillance Program. 2007c. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51(11): 3880-3886. doi:10.1128/AAC.00846-07. PMID:17724154.
306. Simor, A., Stuart, T., Watt, C., Louie, L., Gravel, D., Ofner-Agostini, M., et al. 2007d. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can. J. Infect. Dis. Med. Microbiol. 18: 41.
307. Skulnick, M., Simor, A.E., Gregson, D., Patel, M., Small, G.W., Kreiswirth, B., et al. 1992. Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus. J. Clin. Microbiol. 30(8): 1985-1988. PMID:1500504.
308. Sligl, W., Taylor, G., Gibney, N., Rennie, R., and Chui, L. 2006. Methicillin-resistant Staphylococcus aureus infection in a general systems intensive care unit: epidemiology, antimicrobial susceptibility, and outcomes. Can. J. Infect. Dis. Med. Microbiol. 17: 57.
309. Smith, J.A. 1991. Risk management: an aspect of infection control in an acute care hospital. Can. J. Infect. Control, 6(3): 74-76. PMID:1824286.
310. Stefanovic, A., Champagne, S., Hull, M., Sebastian, R., and Romney, M. 2008. In vitro activity of tigecycline against community and hospital strains of methicillin-resistant Staphylococcus aureus at Providence Health Care. Can. J. Infect. Dis. Med. Microbiol. 19: 99.
311. Stegenga, J., Moore, D., Johnston, L., et al. 2007. Development of a national surveillance system for central venous catheter bloodstream infections: the first six months from the Canadian Nosocomial Infection Surveillance Program. Can. J. Infect. Control, 22: 50.
312. Stewart, G.T., and Holt, R.J. 1963. Evolutio of natural resistance to the newer penicillins. BMJ, 1(5326): 308-311. doi:10.1136/bmj. 1.5326.308. PMID:13984091.
313. Suh, K., Toye, B., Jessamine, P., Chan, F., and Ramotar, K. 1998. Epidemiology of methicillin-resistant Staphylococcus aureus in three Canadian tertiary-care centers. Infect. Control Hosp. Epidemiol. 19(6): 395-400. doi:10.1086/647838. PMID:9669620.
314. Taylor, G., Kirkland, T., Kowalewska-Growchowska, K., and Wang, Y. 1990. A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can. J. Infect. Dis. 1: 121-126.
315. Taylor, G.D., Kibsey, P., Kirkland, T., Burroughs, E., and Tredget, E. 1992. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns, 18(4): 332-335. doi:10.1016/0305- 4179(92)90158-Q. PMID:1418512.
316. Thomas, E., Husak, M., Dawson, L., Kramer, J., and Manickam, K. 2004. Epidemiology of methicillin resistant Staphylococcus aureus in the Regina Qu'Appelle Health Region. Conjoint Mtg. Infect. Dis. 2004: P7. [Abstr.]
317. Thornley, D., Bialachowski, A., Callery, S., Olde, J., Smaill, F., and Loeb, M. 2001. Standardized screening for MRSA. Conjoint Mtg. Infect. Dis. 2001: R3. [Abstr.]
318. Thornsberry, C., and McDougal, L.K. 1983. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J. Clin. Microbiol. 18(5): 1084-1091. PMID:6643661.
319. Van Horne, E., Barry, C., Kotowich, L., Sibbald, G., and Vearncombe, M. 2000. Methicillin-resistant Staphylococcus aureus in an outpatient dermatology day care clinic. Can. J. Infect. Control, 15: 2-3.
320. Vanderkool, O.G., Bryce, E., McGeer, A., et al. 2005. Epidemiology of methicillin resistant Staphylococcus aureus in Canadian children from 1995 to 2002. Conjoint Mtg. Infect. Dis. 2005: P1.11. [Abstr.]
321. Vortel, J.J., Bell, A., Farley, J.D., Shaw, C., Guite, A., and Harper, B. 1991. Methicillin-resistant Staphylococcus aureus (MRSA) in a British Columbia hospital-1990. Can. Dis. Wkly. Rep. 17(14): 71-72. PMID:2054853.
322. Wadas, K., De Souza, E., Gaspard, F., Hebert, G., and Loo, V. 2004. The impact of ICU design on nosocomial MRSA rates. Can. J. Infect. Control, 19: 18.
323. Warshawsky, B., Hussain, Z., Gregson, D.B., Alder, R., Austin, M., Bruckschwaiger, D., et al. 2001. Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect. Control Hosp. Epidemiol. 21(11): 724-727. doi:10.1086/501718.
324. Webster, D., Rennie, R.P., Brosnikoff, C.L., Chui, L., and Brown, C. 2007. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn. Microbiol. Infect. Dis. 57(2): 177-181. doi:10.1016/j.diagmicrobio.2006.07.007. PMID:16938420.
325. Weese, J.S., and Rousseau, J. 2005. Attempted eradication of methicillin-resistant Staphylococcus aureus colonisation in horses on two farms. Equine Vet. J. 37(6): 510-514. doi:10.2746/042516405775314835. PMID:16295927.
326. Weese, J.S., DaCosta, T., Button, L., Goth, K., Ethier, M., and Boehnke, K. 2004. Isolation of methicillin-resistant Staphylococcus aureus from the environment in a veterinary teaching hospital. J. Vet. Intern. Med. 18(4): 468-470. doi:10.1892/0891-6640(2004)18〈468:IOMSAF〉2.0. CO;2. PMID: 15320581.
327. Weese, J.S., Archambault, M., Willey, B.M., Hearn, P., Kreiswirth, B.N., Said-Salim, B., et al. 2005a. Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg. Infect. Dis. 11(3): 430-435. PMID:15757559.
328. Weese, J.S., Rousseau, J., Traub-Dargatz, J.L., Willey, B.M., McGeer, A.J., and Low, D.E. 2005b. Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J. Am. Vet. Med. Assoc. 226(4): 580-583. doi:10.2460/javma.2005.226.580. PMID:15742700.
329. Weese, J.S., Willey, B.M., Dick, H., Kreiswirth, B.N., McGeer, A.J., and Low, D.E. 2005c. Methicillin-resistant Staphylococcus aureus infection and colonization in domestic pets, pet owners and veterinary personnel. Conjoint Mtg. Infect. Dis. 2005: P2.21. [Abstr.]
330. Weese, J.S., Caldwell, F., Willey, B.M., Kreiswirth, B.N., McGeer, A., Rousseau, J., and Low, D.E. 2006a. An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital. Vet. Microbiol. 114(1-2): 160-164. doi:10.1016/j.vetmic.2005.11.054. PMID:16384660.
331. Weese, J.S., Dick, H., Willey, B.M., McGeer, A., Kreiswirth, B.N., Innis, B., and Low, D.E. 2006b. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet. Microbiol. 115(1-3): 148-155. doi:10.1016/j.vetmic.2006.01.004. PMID:16464540.
332. Weese, J.S., Rousseau, J., Willey, B.M., Archambault, M., McGeer, A., and Low, D.E. 2006c. Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J. Vet. Intern. Med. 20(1): 182-186. doi:10.1892/0891-6640(2006)20[182:MSAIHA]2.0.CO;2. PMID:16496939.
333. Weinwurm, D., Plante-Jenkins, C., and Ostrowska, K. 2004. Review mupirocin susceptibility patterns of MRSA to determine impact on decolonization/treatment regimen. Can. J. Infect. Control, 19: 14.
334. Weiss, K.A., Karlowsky, J.A., Kelly, L.J., et al. 2001. Linezolid activity against resistant and multidrug-resistant Gram-positive clinical isolates collected across Canada in 2000-2001. Conjoint Mtg. Infect. Dis. 2001: A4. [Abstr.]
335. nd Inter. Conf. Antimicrob. Agents Chemother., 2002. Abstr. C2-292.
336. Wells, B. 1998. Methicillin resistant Staphylococcus aureus: what works, what doesn't work and cost implications. Can. J. Infect. Control, 13: 13.
337. Wells, B. 2000. Cost effectiveness of total admission screening for methicillin-resistant Staphylococcus aureus on medical wards. Can. J. Infect. Control, 15: 2-3.
338. Wenzel, R.P., Donowitz, L., and Miller, G.B., Jr.; Centers for Disease Control (CDC). 1981. Methicillin-resistant Staphylococcus aureus-United States. MMWR Morb. Mortal. Wkly. Rep. 30(12): 140, 145-147. PMID:6789065.
339. Wicklund, B.M., Dixon, C., and Meakins, J.L. 1982. Methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Can. Dis. Wkly. Rep. 8: 166-168.
340. Willey, B.M., Bertolin, J., Thususka, J., Lai, S., Saiyed, M., Harris, S., et al. 1997. Epidemic methicillin-resistant Staphylococcus aureus (MRSA) in Ontario: failure of routine surveillance and laboratory detection. Conjoint Mtg. Infect. Dis. 1997: H4. [Abstr.]
341. Willey, B.M., Dick, H.L.N., Oughton, M.T., Kreiswirth, B., and Low, D.E. 2003a. Methicillin-resistant Staphylococcus aureus infections in companion animals. Conjoint Mtg. Infect. Dis. 2003: P42. [Abstr.]
342. Willey, B.M., Low, D.E., Archambault, M., Kreiswirth, B.N., McGeer, A., Prescott, J., et al. 2003b. Methicillin-resistant Staphylococcus aureus infection in horses and horse personnel 2000-2002. Conjoint Mtg. Infect. Dis. 2003: D3. [Abstr.]
343. Willey, B.M., Kreiswirth, N., Ho, S., Larocque, C., Lum, M., Pike, K., et al. 2006. Validation of disc diffusion for detection of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus. Can. J. Infect. Dis. Med. Microbiol. 17: 69-70.
344. Willey, B.M., Poutanen, S., Green, K., et al. 2007. The introduction of Panton-Valentine leukocidin-positive SCCmec type IV methicillin-resistant Staphylococcus aureus into Canada, 2002-2005. Can. J. Infect. Dis. Med. Microbiol. 18: 52.
345. Willey, B.M., Borgundvaag, B., Svoboda, T., et al. 2008. Surveillance for methicillin-resistant Staphylococcus aureus at a Toronto community shelter: molecular and antimicrobial resistance characteristics. Can. J. Infect. Dis. Med. Microbiol. 19: 126.
346. Wilson, S., McIlveen, K.H., Boone, J., Wulfe, D., Morrel, L., Stanley, J., et al. 2001. A multidisciplinary team approach controls MRSA transmission on an acute care of the elderly unit. Conjoint Mtg. Infect. Dis. 2001: P66. [Abstr.]
347. Wodinsky, H.B. 1984. Cost analysis of the Kozak protocol as used in an Ontario hospital in the treatment of children with epidermolysis bullosa. CMAJ, 130: 715-717.
348. Wong, H., Louie, L., Watt, C., Sy, E., Lo, R.Y.C., Mulvey, M.R., et al. 2009. Characterization of ermA in macrolide-susceptible strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 538: 3602-3603. doi:10.1128/AAC.00313-09.
349. Wylie, J.L., and Nowicki, D.L. 2004. Community- and healthcare-acquired methicillin-resistant Staphylococcus aureus in Manitoba. Conjoint Mtg. Infect. Dis. 2004: B1. [Abstr.]
350. Wylie, J.L., and Nowicki, D.L. 2005. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J. Clin. Microbiol. 43(6): 2830-2836. doi:10.1128/JCM.43.6.2830-2836.2005. PMID:15956405.
351. Wylie, J.L., Giercke, S., Gray, M., and Phippen, D. 1997. Methicillin-resistant Staphylococcus aureus in rural Manitoba. Conjoint Mtg. Infect. Dis. 1997: D5. [Abstr.]
352. Yao, J., Ramotar, K., Henderson, E., Krulicki, W., and Louie, T.J. 1992. Molecular epidemiologic investigation of methicillin-resistant Staphylococcus aureus infections at a tertiary care hospital. Clin. Invest. Med. 15(Suppl.): A77.
353. Yow, O., Callery, S., Simor, A., and Vearncombe, M. 2007. Surveillance methods for the management of methicillin resistant Staphylococcus aureus in a Canadian long-term care facility. Can. J. Infect. Control, 22: 43.
354. Zaher, A., al-Thawadi, S., and Cimolai, N. 1997. b-lactamase negative, methicillin-resistant Staphylococcus aureus lacking the mecA gene determinant. J. Antimicrob. Chemother. 39(1): 108-109. doi:10.1093/jac/39.1.108. PMID:9044038.
355. Zhanel, G.G., DeCorby, M., Laing, N., Weshnoweski, B., Vashisht, R., Tailor, F., et al.; Canadian Antimicrobial Resistance Alliance (CARA). 2008a. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob. Agents Chemother. 52(4): 1430-1437. doi:10.1128/AAC.01538-07. PMID:18285482.
356. Zhanel, G.G., Decorby, M., Nichol, K.A., Baudry, P.J., Karlowsky, J.A., Lagace-Wiens, P.R., et al. 2008b. Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum b-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). Can. J. Infect. Dis. Med. Microbiol. 19(3): 243-249. PMID:19412382.
357. Zhang, K., McClure, J.A., Elsayed, S., Louie, T., and Conly, J.M. 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43(10): 5026-5033. doi:10.1128/JCM.43.10. 5026-5033.2005. PMID:16207957.
358. Zhang, K., McClure, J., Elsayed, S., Golding, L., Louie, T., and Conly, J. 2006. Temporal evolution of staphylococcal cassette chromosome mec (SCCmec) types and antimicrobial resistance profiles of methicillin-resistant Staphylococcus aureus. Can. J. Infect. Dis. Med. Microbiol. 17: 43.
359. Zhang, K., McClure, J.A., Elsayed, S., Tan, J., and Conly, J.M. 2008. Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J. Infect. Dis. 197(2): 195-204. doi:10.1086/523763. PMID:18173361.
360. Zhang, K., McClure, J.A., Elsayed, S., and Conly, J.M. 2009. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53(2): 531-540. doi:10.1128/AAC.01118-08. PMID:19064897.
361. Zoutman, D.E., and Ford, B.D. 2008. A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: pre- and post-severe acute respiratory syndrome. Am. J. Infect. Control, 36(10): 711-717. doi:10.1016/j.ajic.2008.02.008. PMID:18834747.
362. Zoutman, D.E., Ford, B.D., and Gauthier, J. 2007. A cross Canada survey of infection control resources and programming in long-term care facilities. Can. J. Infect. Control, 22: 40.